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Absence of awareness of 
primary HIV infection
S ir— The Lancet’s series on HIV 
provided valuable,, timely information. 
However, the issues concerning clinical 
care of the HIV-infected individual 
were fragmented because of the many 
subspecialities involved, and thus 
important issues in primary care were 
lost. A striking example of this neglect 
was the way primary HIV infection was 
dealt with. Several contributors failed 
to denote important aspects of acute 
infection (eg, clinical picture and 
laboratory diagnosis), and some 
inaccurate statements were made (ie, 
“primary HIV infection is commonly 
symptomless” and “is sometimes 
identifiable” )*1 Many experts will agree 
that die importance of primary HIV 
infection cannot be overemphasised2,3 
for the following reasons.
First* symptomatic primary HIV 
infection is by no means rare. Its 
occurrence has been reported in 
53-93% of cases with seroconversion 
for HIV-1 .2 Factors to increase the 
recognition rate of primary HIV 
infection seem to be a health-care 
system with easy access, and high level 
of awareness in community 
practitioners and in individuals at risk. 
Second, by contrast with the belief that 
the diagnosis of acute HIV infection is 
scarcely feasible, diagnosis would be 
possible in most patients with 
symptoms if a simple method were 
used—the p24 antigen test. Third, 
recognition of primary HIV infection 
could have considerable consequences 
for the affected individual.'1 By treating 
someone immediately during acute 
primary HIV infection with highly 
active antiretroviral therapy, one might 
be able to blunt the dissemination of 
virus throughout lymphoid tissue. As a 
result* the immune system might be 
able to contain the virus effectively, as 
discussed by Feinberg .5 Fourth, 
recognition of primary HIV infection 
allows counselling of young individuals, 
at an age when they do not often need 
medical help.
Prompt diagnosis of primary HIV 
infection allows counselling and a high 
chance to change risk behaviour at an 
early and, given the high level of
viraemia, contagious stage of infection. 
In addition, identification of a patient 
with primary HIV infection necessarily 
implies die existence of a source case of 
infection, and therefore contact tracing 
might be more feasible. Altogether 
these interventions could have a great 
impact on the spread of the epidemic. 
Last, we should not miss the unique 
opportunity to learn more about how 
the immune system combats HIV by 
studying acute infection. Thus, every 
effort should be made to recognise and 
diagnose symptomatic primary HIV 
infection.
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Change in male:female 
ratio among newborn 
babies in Netherlands
Sir—Mailer (Sept 2 1 , p 829)J reports a 
decline in the proportion of male 
newborn babies in Denmark between 
1951 and 1995, possibly indicative of 
new reproductive hazards ascribed to 
environmental oestrogens, If this 
hypothesis holds true, a similar decline 
in other countries with such chemical 
exposures would be expected. 
Therefore, we analysed the data on 
newborn babies in the Netherlands, 
provided by the Central Bureau of
Statistics, to test the Danish hypothesis, 
and used linear regression analysis.
The male proportion of newborn 
infants in the Netherlands decreased 
significantly from 0*516 in 1950 to 
0-513 in 1994, which is similar to the 
decrease found in Denmark (figure). 
Annually, the male proportion 
decreased by 0*083 per 1000 livebirdis 
(95% C l 0*110-0*057 per 1000 births). 
Between 1950 and 1954, the male to 
female ratio was somewhat higher than 
in later yearsj excluding this period 
from the analysis, the decrease in the 
male proportion remained statistically 
significant with an annual decrease of 
0-058 per 1000 births (0*028-0-089).
Our finding of a decreasing ratio of 
male to female newborn babies in the 
Netherlands can only add to concern 
about the potential hazards of 
environmental endocrine disrupters.2’5 
Investigations should continue into the 
short-term and long-term effects of 
chemicals on human reproduction.
*Karin M van der Pal-de Bruin, S Pauline 
Verioove-Vanhorick, Nel Roeleveld
*TN0 Institute for Prevention and Hlth, P0 Box 2215, 
2301 CE Leiden, Netherlands; and Department of 
Epidemiology, University of Nijmegen, 6500 HB 
Nijmegen
1 Mailer H . Change in male:female ratio 
among newborn infants in Denmark. Lancet 
1996; 348: 828-29,
2 Medical Research Council Institute for 
Environment and Healdi, University of 
Leicester. IEH assessment on environmental 
oestrogens: consequences to human health 
and wildlife. Leicester; Institute for 
Environment and Health, 1995; 1-107.
3 Ministry o f Environment and Energy,
Danish Environmental Protection Agency. 
Male reproductive health and environmental 
chemicals with oestrogenic effects. 
Copenhagen: Ministry of Environment and 
Energy* 1995; 1-166.
4 Toppari J, Larsen J Chr, Christiansen P3 
et al. Male reproductive healdi and 
environmental xenoestrogens.
Environ Health Perspect 1996; 104: 741-803.
5 Kavlack RJ3 Daston GP, DeRosa C. 
Research needs for the risk assessment of 
health and environmental effects of 
endocrine disruptors; a report of the US 
EPA-sponsored workshop.
Environ Health Perspect 1996; 104:
715-40.
<n<D
jQ(0X)
oJO
sc
Ü)
a
£
co
oao
L -
CL
0-518-
0-516
0-514-
0-512-
0*510-
0-508-
0-506
^  /O QÖ 
• p  $
Year
&
Proportion of male newborn babies in Netherlands, 1950 -9 4
Points represent single years (y=0-677-year; p=<0-001).
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